levodopa	is a	drug
levodopa	treats	Parkinson’s disease
levodopa	combined with	carbidopa
carbidopa	prevents	peripheral metabolism
levodopa	improves	motor symptoms
levodopa	causes	dyskinesia
levodopa	dosage	100–200 mg
levodopa	administered	orally
levodopa	contraindicated in	dementia
levodopa	reduces	mortality
pramipexole	is a	dopamine agonist
pramipexole	treats	Parkinson’s disease
pramipexole	reduces	motor fluctuations
pramipexole	causes	nausea
pramipexole	dosage	0.125–1.5 mg
pramipexole	administered	orally
pramipexole	contraindicated in	severe heart failure
ropinirole	is a	dopamine agonist
ropinirole	treats	Parkinson’s disease
ropinirole	reduces	OFF periods
ropinirole	causes	hallucinations
ropinirole	dosage	0.25–2.5 mg
ropinirole	administered	orally
ropinirole	contraindicated in	uncontrolled hypertension
bromocriptine	is a	dopamine agonist
bromocriptine	treats	Parkinson’s disease
bromocriptine	causes	orthostatic hypotension
bromocriptine	dosage	1.25–5 mg
bromocriptine	administered	orally
bromocriptine	contraindicated in	severe cardiac disease
cabergoline	is a	dopamine agonist
cabergoline	treats	Parkinson’s disease
cabergoline	causes	nausea
cabergoline	dosage	0.5–1.5 mg
cabergoline	administered	orally
cabergoline	contraindicated in	valvular heart disease
selegiline	is a	MAO-B inhibitor
selegiline	treats	Parkinson’s disease
selegiline	reduces	oxidative stress
selegiline	causes	insomnia
selegiline	dosage	5–10 mg
selegiline	administered	orally
selegiline	contraindicated in	tyramine‑rich diet
rasagiline	is a	MAO-B inhibitor
rasagiline	treats	Parkinson’s disease
rasagiline	reduces	neurotoxicity
rasagiline	causes	nausea
rasagiline	dosage	1 mg
rasagiline	administered	orally
rasagiline	contraindicated in	severe hepatic impairment
entacapone	is a	COMT inhibitor
entacapone	treats	Parkinson’s disease
entacapone	prolongs	levodopa action
entacapone	causes	diarrhea
entacapone	dosage	200 mg
entacapone	administered	orally
entacapone	contraindicated in	severe renal disease
tolcapone	is a	COMT inhibitor
tolcapone	treats	Parkinson’s disease
tolcapone	causes	hepatotoxicity
tolcapone	dosage	100 mg
tolcapone	administered	orally
tolcapone	contraindicated in	liver disease
apomorphine	is a	dopamine agonist
apomorphine	treats	Parkinson’s disease
apomorphine	used for	OFF episodes
apomorphine	causes	nausea
apomorphine	dosage	0.5–2 mg
apomorphine	administered	subcutaneous
apomorphine	contraindicated in	severe cardiac disease
bromocriptine	combined with	levodopa
levodopa	combined with	entacapone
levodopa	combined with	selegiline
pramipexole	combined with	levodopa
ropinirole	combined with	levodopa
cabergoline	combined with	levodopa
rasagiline	combined with	levodopa
entacapone	combined with	levodopa
tolcapone	combined with	levodopa
apomorphine	combined with	levodopa
levodopa	increases	dopamine levels
dopamine agonists	mimic	dopamine
MAO-B inhibitors	prevent	dopamine breakdown
COMT inhibitors	prevent	levodopa metabolism
levodopa	associated with	motor complications
dopamine agonists	associated with	impulse control disorders
MAO-B inhibitors	associated with	neuroprotection
COMT inhibitors	associated with	extended levodopa duration
levodopa	improves	gait
dopamine agonists	improve	quality of life
MAO-B inhibitors	reduce	oxidative damage
COMT inhibitors	reduce	levodopa peak‑trough variability
levodopa	contraindicated in	severe hepatic disease
dopamine agonists	contraindicated in	severe psychiatric illness
MAO-B inhibitors	contraindicated in	tyramine‑rich diet
COMT inhibitors	contraindicated in	renal impairment
levodopa	dosage adjustment	in renal impairment
dopamine agonists	dosage adjustment	in elderly
MAO-B inhibitors	dosage adjustment	in hepatic impairment
COMT inhibitors	dosage adjustment	in renal impairment
